New Zealand markets close in 3 hours 33 minutes
  • NZX 50

    11,377.98
    +0.86 (+0.01%)
     
  • NZD/USD

    0.5970
    +0.0003 (+0.05%)
     
  • NZD/EUR

    0.5637
    +0.0008 (+0.14%)
     
  • ALL ORDS

    7,266.50
    -12.10 (-0.17%)
     
  • ASX 200

    7,063.90
    -12.60 (-0.18%)
     
  • OIL

    89.69
    +0.01 (+0.01%)
     
  • GOLD

    1,934.80
    -1.80 (-0.09%)
     
  • NASDAQ

    14,768.90
    +67.80 (+0.46%)
     
  • FTSE

    7,623.99
    -59.92 (-0.78%)
     
  • Dow Jones

    34,006.88
    +43.04 (+0.13%)
     
  • DAX

    15,405.49
    -151.80 (-0.98%)
     
  • Hang Seng

    17,729.29
    -328.16 (-1.82%)
     
  • NIKKEI 225

    32,575.38
    -103.24 (-0.32%)
     
  • NZD/JPY

    88.7490
    -0.0220 (-0.02%)
     

Why Madrigal Pharmaceuticals Stock Is Marching Higher Today

Why Madrigal Pharmaceuticals Stock Is Marching Higher Today

Shares of the clinical-stage drugmaker Madrigal Pharmaceuticals (NASDAQ: MDGL) were up by 6.2% on elevated volume as of 12:16 p.m. ET Wednesday. The biotech appears to be benefiting from two key tailwinds. First, a Food and Drug Administration (FDA) panel voted overwhelmingly last Friday against approving Intercept Pharmaceuticals' (NASDAQ: ICPT) candidate, obeticholic acid, for treating pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).